We report a case of Felty’s syndrome with pleural effusion as the initial symptom and the subsequent diagnosis and treatment of the patient’s secondary pyothorax. Case presentation: We report the case ...

Rapidly recurrent malignant pleural effusions are not uncommon in patients with carcinoma of the breast, lung, uterus and so forth. The associated severe dyspnea is often the most distressing symptom.

As well as the IPF candidate, the merger gave Aileron a phase-2b-ready treatment for loculated pleural effusions and a cystic fibrosis program. Finding funding for the programs remains an issue.

The following is a summary of “Predictors of lung entrapment in malignant pleural effusion,” published in the November 2024 issue of Pulmonology by Trovisco et al. Researchers conducted a ...

At age 9 years, after surgical pleurodesis and repeated selective lymphatic embolisation, the pleural effusions stabilised in size becoming chronic and loculated on medical therapy of furosemide and ...

Aileron's second product candidate, LTI-01, is a proenzyme that has completed Phase 1b and Phase 2a clinical trials for the treatment of loculated pleural effusions.

Aileron's second product candidate, LTI-01, is a proenzyme that has completed Phase 1b and Phase 2a clinical trials for the treatment of loculated pleural effusions.

Pleural infection is usually treated with empirical broad-spectrum antibiotics, but limited data exist on their penetrance into the infected pleural space. We performed a pharmacokinetic study ...

LTI-01 is under development for the treatment of loculated pleural effusions and empyema. It is administered through intrapleural route. It is a proenzyme or zymogen and becomes activated in the ...

Hemorrhagic pleural effusion occurs when fluid accumulates in the visceral pleura due to fluid production exceeding the removal rate.